Breaking News

Wednesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
ITRM

Iterum Therapeutics

$7.25

0.16 (2.26%)

07:51
05/15/19
05/15
07:51
05/15/19
07:51
Recommendations
Iterum Therapeutics analyst commentary at RBC Capital »

Iterum Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Tuesday
ITRM

Iterum Therapeutics

$7.09

(0.00%)

07:08
05/14/19
05/14
07:08
05/14/19
07:08
Earnings
Iterum Therapeutics reports Q1 EPS ($1.44), consensus ($1.35) »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a month ago
ITRM

Iterum Therapeutics

$8.85

(0.00%)

07:41
04/11/19
04/11
07:41
04/11/19
07:41
Hot Stocks
Iterum Therapeutics to present three posters at ECCMID »

Iterum Therapeutics will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ITRM

Iterum Therapeutics

$7.28

-0.02 (-0.27%)

07:09
03/25/19
03/25
07:09
03/25/19
07:09
Earnings
Iterum Therapeutics reports Q4 EPS ($1.19), consensus ($2.25) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ITRM

Iterum Therapeutics

$5.63

0.16 (2.93%)

07:05
03/19/19
03/19
07:05
03/19/19
07:05
Hot Stocks
Iterum Therapeutics receives QIDP for oral, IV sulopenem in four new indications »

Iterum Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

ITRM

Iterum Therapeutics

$5.63

0.16 (2.93%)

04:55
03/19/19
03/19
04:55
03/19/19
04:55
Conference/Events
Iterum Therapeutics management to meet with Needham »

Meeting to be held in Los…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

ITRM

Iterum Therapeutics

$5.51

0.75 (15.76%)

15:09
03/15/19
03/15
15:09
03/15/19
15:09
Conference/Events
Iterum Therapeutics management to meet with Needham »

Meeting to be held in Los…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

Over a quarter ago
ITRM

Iterum Therapeutics

$7.69

(0.00%)

04:55
12/11/18
12/11
04:55
12/11/18
04:55
Conference/Events
Iterum Therapeutics management to meet with RBC Capital »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

ITRM

Iterum Therapeutics

$7.69

0.22 (2.95%)

09:13
12/10/18
12/10
09:13
12/10/18
09:13
Conference/Events
Iterum Therapeutics management to meet with RBC Capital »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

ALDX

Aldeyra

$10.08

-0.19 (-1.85%)

, EOLS

Evolus

$14.59

-0.13 (-0.88%)

04:55
11/14/18
11/14
04:55
11/14/18
04:55
Conference/Events
Stifel to hold a conference »

2018 Healthcare…

ALDX

Aldeyra

$10.08

-0.19 (-1.85%)

EOLS

Evolus

$14.59

-0.13 (-0.88%)

LXRX

Lexicon

$8.41

0.06 (0.72%)

KURA

Kura Oncology

$11.58

0.11 (0.96%)

URGN

UroGen Pharma

$46.33

0.83 (1.82%)

MNTA

Momenta

$12.79

-0.36 (-2.74%)

ASRT

Assertio Therapeutics

$5.38

(0.00%)

ATEC

Alphatec

$2.85

-0.13 (-4.36%)

ITRM

Iterum Therapeutics

$5.92

0.21 (3.68%)

CUTR

Cutera

$20.32

0.24 (1.20%)

IBIO

iBio

$0.78

0.045 (6.16%)

HRC

Hill-Rom

$93.52

-0.9 (-0.95%)

TRXC

TransEnterix

$2.88

-0.2 (-6.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 14

    Nov

  • 14

    Nov

  • 27

    Nov

  • 27

    Nov

  • 01

    Dec

  • 02

    Feb

  • 22

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.